Increasing Cancer Research to Bolster Middle East & Africa Butterfly Needles Market Growth During Forecast Period
An intravenous (IV) needle is used to administer chemotherapy for cancer treatment. The medicine is administered directly into the bloodstream through a butterfly needle inserted into the upper arm or hand vein. Cancer is a major and increasing health problem, driving efforts of different national governments to address the problem. Cancer research primarily focuses on various opportunities, including studying populations that are at high risk of cancer, developing drugs and vaccines that do not require refrigeration, and establishing biobanks to manage biospecimens. A multi-level approach is required to advance clinical research, involving collaboration between the pharma industry, regulators, government, and healthcare professionals. Thus, increasing number of cancer cases and rising cancer-related research activities across the region are expected to provide lucrative Middle East & Africa butterfly needles market growth opportunities during the forecast period.
Middle East & Africa Butterfly Needles Market Overview
The Middle East & Africa butterfly needles market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia is expected to account for the largest market share and is expected to develop moderately in the Middle East & Africa during the forecast period. To improve healthcare services, public organizations and the government have initiated programs to enhance the use of butterfly needles in the country. In the last few years, the private sector has been playing an important role in the healthcare system in Saudi Arabia owing to the rising investments, which helps in the development of healthcare facilities and infrastructure in the country. The government of Saudi Arabia has launched the Saudi Vision 2030 program to reduce oil dependence and diversify other sectors, including healthcare. Association of friends of the National Cancer Institute (AFNCI) organized 150 campaigns and collected 3,764 blood bags in 2020. Furthermore, rising prevalence of chronic disorders among the elder population and genetic blood disorders among children has increased the demand for butterfly needles. As per the Saudi Medical Journal, Saudi Arabia has had the highest prevalence rate of hemoglobinopathies, including sickle cell anemia and thalassemia. Additionally, β-thalassemia was identified as having a prevalence of 1.8% (29,006 patients) among tested people, confirming a higher prevalence of hemoglobinopathies in the Saudi population in 2021. These needles are widely used owing of the various advantages offered by these needles make them versatile with minimal nerve injury. Therefore, the rising prevalence of chronic disorders is driving the growth of the Middle East & Africa butterfly needles market.
The Middle East & Africa butterfly needles market is segmented based on application, end user, and country.
Based on application, the Middle East & Africa butterfly needles market is segmented into blood collection, IV rehydration, delivery of medications, venipuncture, and blood transfusion. The blood collection segment held the largest Middle East & Africa butterfly needles market share in 2022.
Based on end user, the Middle East & Africa butterfly needles market is segmented into hospitals, clinics, blood banks, and others. The hospitals segment held the largest Middle East & Africa butterfly needles market share in 2022.
Based on country, the Middle East & Africa butterfly needles market has been categorized into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Our regional analysis states that the Rest of Middle East & Africa dominated the Middle East & Africa butterfly needles market in 2022.
B. Braun SE, Becton Dickinson and Co, Cardinal Health Inc, ICU Medical Inc, Medline Industries Inc, Nipro Corp, and Terumo Corp are the leading companies operating in the Middle East & Africa butterfly needles market.